首页> 美国卫生研究院文献>The Oncologist >The Significance of Early Alpha-Fetoprotein Level Changes in Predicting Clinical and Survival Benefits in Advanced Hepatocellular Carcinoma Patients Receiving Sorafenib

【2h】

The Significance of Early Alpha-Fetoprotein Level Changes in Predicting Clinical and Survival Benefits in Advanced Hepatocellular Carcinoma Patients Receiving Sorafenib

机译：早期甲胎蛋白水平变化对索拉非尼晚期肝癌患者预测临床和生存获益的意义

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

Background.The role of serum alpha-fetoprotein (AFP) changes in predicting the treatment outcomes of advanced hepatocellular carcinoma (HCC) patients to sorafenib remains unknown.

机译：背景：血清甲胎蛋白（AFP）变化在预测晚期肝细胞癌（HCC）患者对索拉非尼的治疗结果中的作用仍然未知。

著录项

期刊名称 The Oncologist
作者
Thomas Yau; T.J. Yao; Pierre Chan; Hilda Wong; Roberta Pang; Sheung Tat Fan; Ronnie T.P. Poon;
展开▼
作者单位

展开▼
年(卷),期 2011(16),9
年度 2011
页码 1270–1279
总页数 10
原文格式 PDF
正文语种
中图分类肿瘤学 ;
关键词
Hepatocellular carcinoma Sorafenib Alpha-fetoprotein Surrogate;

机译：肝细胞癌;索拉非尼;甲胎蛋白;替代;

相似文献

外文文献
中文文献
专利

1. The significance of early alpha-fetoprotein level changes in predicting clinical and survival benefits in advanced hepatocellular carcinoma patients receiving sorafenib. [J] . Yau T, Yao TJ, Chan P, The oncologist . 2011 ,第9期

机译：早期甲胎蛋白水平变化对接受索拉非尼的晚期肝细胞癌患者预测临床和生存获益的意义。
2. The Significance of Early Alpha-Fetoprotein Level Changes in Predicting Clinical and Survival Benefits in Advanced Hepatocellular Carcinoma Patients Receiving Sorafenib [J] . Thomas Yau, T.J. Yao, Pierre Chan, The oncologist . 2011 ,第9期

机译：早期甲胎蛋白水平变化对索拉非尼晚期肝癌患者预测临床和生存获益的意义
3. High circulating endothelial progenitor levels associated with poor survival of advanced hepatocellular carcinoma patients receiving sorafenib combined with metronomic chemotherapy. [J] . Shao YY, Lin ZZ, Chen TJ, Oncology: International Journal of Cancer Research and Treatment . 2011 ,第2期

机译：循环内皮祖细胞水平高与接受索拉非尼联合节律化疗的晚期肝细胞癌患者生存期差有关。
4. Kinetic Textural Biomarker for Predicting Survival of Patients with Advanced Hepatocellular Carcinoma After Antiangiogenic Therapy by Use of Baseline First-Pass Perfusion CT [C] . Sang Ho Lee, Koichi Hayano, Dushyant V. Sahani, International conference on medical image computing and computer-assisted intervention;International workshop on abdominal imaging: computational and clinical applications . 2014

机译：动力学纹理生物标志物通过基线首过灌注CT预测抗血管生成治疗后晚期肝细胞癌患者的生存率
5. Poly(lactide-co-glycolide) Microspheres for Localized, Magnetic Resonance Imaging Monitored, Transcatheter Delivery of Sorafenib to Hepatocellular Carcinoma. [D] . Chen, Jeane. 2015

机译：聚（丙交酯-共-乙交酯）微球体用于局部监测，磁共振成像监测，索拉非尼经导管输送至肝细胞癌。
6. Serum cytokine profiles predict survival benefits in patients with advanced hepatocellular carcinoma treated with sorafenib: a retrospective cohort study [O] . Tomoyuki Hayashi, Taro Yamashita, Takeshi Terashima, 2017

机译：血清细胞因子谱预测索拉非尼治疗晚期肝细胞癌患者的生存获益：一项回顾性队列研究
7. The significance of early alpha-fetoprotein level changes in predicting clinical and survival benefits in advanced hepatocellular carcinoma patients receiving sorafenib [O] . Yao, TJ, Poon, RTP, Fan, ST, 2011

机译：早期甲胎蛋白水平变化对预测接受索拉非尼的晚期肝细胞癌患者临床和生存获益的意义

The Significance of Early Alpha-Fetoprotein Level Changes in Predicting Clinical and Survival Benefits in Advanced Hepatocellular Carcinoma Patients Receiving Sorafenib

摘要

著录项

相似文献

相关主题

期刊订阅